Table 4 Differences for M/SP prevalence and pain therapy for M/SP between the two departments
| Â | Oncohematology Department | Surgery Department | p-value |
|---|---|---|---|
Patients n | 21 | 42 | Â |
Patients with M/S P | 9 | 23 | Â |
M/SP During hospitalization | 43% (9/21) | 55% (23/42) | 0.373 |
M/SP 24Â h before interview | 14% (3/21) | 40% (17/42) | 0.046 |
At time of interview | 5% (1/21)) | 21% (9/42) | 0.144 |
Mean value PMI | -1 | -2 | < 0.001 |
Standard Deviation PMI | ± 0.7 | ± 0.7 | |
Minimum PMI | -2 | -3 | Â |
Maximum PMI | 0 | 0 | Â |
PMI < 0 (undertreated Pain) | 78% (7/9) | 91% (21/23) | 0.557 |
PMI = or > 0 | 22% (2/9) | 9% (2/23) |  |
Time Based therapy | 67% (6/9) | 61% (14/23) | 1.000 |
Intermittent Therapy | 33% (3/9) | 17% (4/23) | 0.370 |
No Therapy | 0 | 22% (5/23 | 0.288 |
Multimodal Analgesia | 11% (1/9) | 13% (3/23) | 1.000 |
Opioids alone | 22% (2/9) | 0 | 0.073 |